a developer of therapeutics based on RNA interference
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AWMIX | 19.43 | 0.03 | +0.15% |
CIBC Atlas Mid Cap Equity Institutional | |||
IJPTX | 12.27 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
RECAX | 12.82 | N/A | N/A |
RBC Emerging Markets Ex-China Equity A | |||
ODMAX | 39.81 | -0.12 | -0.30% |
Invesco Developing Markets A | |||
CISGX | 15.57 | -0.10 | -0.64% |
Touchstone Sands Capital Select Gr Instl |
A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with OCGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then OCGN could also see price increases.
Ticker / NAME | Correlation To ALNY | 1D Price Change % | ||
---|---|---|---|---|
ALNY | 100% | +0.60% | ||
OCGN - ALNY | 49% Loosely correlated | +1.87% | ||
ATRA - ALNY | 44% Loosely correlated | -2.64% | ||
IONS - ALNY | 42% Loosely correlated | +2.25% | ||
SGMO - ALNY | 42% Loosely correlated | +20.00% | ||
AMLX - ALNY | 40% Loosely correlated | N/A | ||
More |